BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27234029)

  • 1. Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery.
    Jia Z; Liu Y; Guan N; Bo X; Luo Z; Barnes MR
    BMC Genomics; 2016 May; 17():414. PubMed ID: 27234029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures.
    Emon MA; Domingo-Fernández D; Hoyt CT; Hofmann-Apitius M
    BMC Bioinformatics; 2020 Jun; 21(1):231. PubMed ID: 32503412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug target prediction and repositioning using an integrated network-based approach.
    Emig D; Ivliev A; Pustovalova O; Lancashire L; Bureeva S; Nikolsky Y; Bessarabova M
    PLoS One; 2013; 8(4):e60618. PubMed ID: 23593264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
    Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
    BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Large-Scale Chemically-Induced Transcriptome Data Acquired from LINCS to Study Small Molecules.
    Iwata M; Yamanishi Y
    Methods Mol Biol; 2019; 1888():189-203. PubMed ID: 30519948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NFFinder: an online bioinformatics tool for searching similar transcriptomics experiments in the context of drug repositioning.
    Setoain J; Franch M; Martínez M; Tabas-Madrid D; Sorzano CO; Bakker A; Gonzalez-Couto E; Elvira J; Pascual-Montano A
    Nucleic Acids Res; 2015 Jul; 43(W1):W193-9. PubMed ID: 25940629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
    Bayraktar A; Li X; Kim W; Zhang C; Turkez H; Shoaie S; Mardinoglu A
    J Transl Med; 2023 May; 21(1):332. PubMed ID: 37210557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug-gene interaction networks analysis.
    MotieGhader H; Tabrizi-Nezhadi P; Deldar Abad Paskeh M; Baradaran B; Mokhtarzadeh A; Hashemi M; Lanjanian H; Jazayeri SM; Maleki M; Khodadadi E; Nematzadeh S; Kiani F; Maghsoudloo M; Masoudi-Nejad A
    Sci Rep; 2022 Jun; 12(1):9417. PubMed ID: 35676421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
    Turanli B; Gulfidan G; Arga KY
    OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gene2drug: a computational tool for pathway-based rational drug repositioning.
    Napolitano F; Carrella D; Mandriani B; Pisonero-Vaquero S; Sirci F; Medina DL; Brunetti-Pierri N; di Bernardo D
    Bioinformatics; 2018 May; 34(9):1498-1505. PubMed ID: 29236977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening novel drug candidates for Alzheimer's disease by an integrated network and transcriptome analysis.
    Peng Y; Yuan M; Xin J; Liu X; Wang J
    Bioinformatics; 2020 Nov; 36(17):4626-4632. PubMed ID: 32516365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconciling multiple connectivity scores for drug repurposing.
    Samart K; Tuyishime P; Krishnan A; Ravi J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mantra 2.0: an online collaborative resource for drug mode of action and repurposing by network analysis.
    Carrella D; Napolitano F; Rispoli R; Miglietta M; Carissimo A; Cutillo L; Sirci F; Gregoretti F; Di Bernardo D
    Bioinformatics; 2014 Jun; 30(12):1787-8. PubMed ID: 24558125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PATHOME-Drug: a subpathway-based polypharmacology drug-repositioning method.
    Nam S; Lee S; Park S; Lee J; Park A; Kim YH; Park T
    Bioinformatics; 2022 Jan; 38(2):444-452. PubMed ID: 34515762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel individualized drug repositioning approach for predicting personalized candidate drugs for type 1 diabetes mellitus.
    Zheng H
    Stat Appl Genet Mol Biol; 2019 Jul; 18(5):. PubMed ID: 31287801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Integrated System Biology Approach Yields Drug Repositioning Candidates for the Treatment of Heart Failure.
    Yang G; Ma A; Qin ZS
    Front Genet; 2019; 10():916. PubMed ID: 31608126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying Gene Signatures for Cancer Drug Repositioning Based on Sample Clustering.
    Wang F; Ding Y; Lei X; Liao B; Wu FX
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(2):953-965. PubMed ID: 32845842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PhenoPredict: A disease phenome-wide drug repositioning approach towards schizophrenia drug discovery.
    Xu R; Wang Q
    J Biomed Inform; 2015 Aug; 56():348-55. PubMed ID: 26151312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.